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A 
friend recently asked me why a small 
can of tomato juice needs to contain 
880 mg of NaCl. He assumed that 
nephrologists would know the answer 
and also probably would oppose this as a public-
health hazard. He was correct on both counts. 
Salt is added to all prepared food for an obvious 
reason: it is the best preservative we know of. It is 
bacteriostatic and does not radically change the 
character of the food regardless of its composition; 
hence it is used in materials as diff erent as fruit 
juices, ice cream, and meat. But there is a more 
subtle reason for its use: preserving food oft en 
causes an unpleasant, bitter taste, and it has been 
well documented that increasing salt concentra-
tion suppresses bitter taste.1 Th ere is also some 
evidence that salt enhances sweet taste; hence, by 
adding salt, one can make food more palatable. 
No wonder every processed or canned food in 
the marketplace is salty. Given that consumption 
of prepared and canned food is increasing, the 
intake of salt in industrialized countries is now 
pretty high.
How good is the evidence that a high-salt diet is 
detrimental to health? A fair analysis of epidemio-
logical, genetic, and intervention studies shows an 
overwhelming connection. Hence the presence 
of a high salt content in processed food requires 
defense, and the food industry has risen to this 
challenge. Th e Salt Institute, a powerful lobbying 
group composed of salt manufacturers but also 
supported by a variety of industries including the 
prepared-food industry, has led the fi ght to show 
that salt is actually good for you. Th eir strategy 
has been to invent controversy to show that there 
are two sides to each issue, a well-known political 
trick! Touting the few studies that raise questions 
as to whether there is a relationship between salt 
and high blood pressure, their dissemination of 
this information has been so eff ective that, every-
where you look — say, in major newspapers — 
the idea that a high-salt diet causes high blood 
pressure is now considered controversial. Th is 
is not the place to go over all the epidemiologi-
cal evidence that links high salt to hypertension 
and heart disease. But I want to point out that the 
evidence is not only (I really want to say merely) 
epidemiological. Chimpanzees raised on a high-
salt diet developed an increase in blood pressure 
with ageing, whereas their siblings raised on a 
low-salt diet did not.2 All the mendelian diseases 
associated with hypertension include defects that 
cause increases in salt absorption by the kidney.3 
Large organizations such as the National Insti-
tutes of Health (NIH) and the American Heart 
Association believe there is a relationship and 
have recommended the reduction of salt intake, 
but such a decision can never be taken lightly.
Of course, propagandists have discovered that, 
these days, when institutions with authority 
need to be attacked, they are best cast as purvey-
ors of orthodoxy and political correctness. Th e 
view of the NIH and the American Heart Asso-
ciation is simply a refl ection of the consensus of 
most experts in the fi eld. However, there are a 
few researchers who say it ain’t necessarily so.4 
Michael Alderman, a prominent epidemiologist, 
says that his problem with the data is that they 
are “observational” — that is, epidemiological. 
Alderman is the Salt Institute’s hero and was a 
featured speaker at their 92nd annual meeting in 
March 2006. Because epidemiology cannot prove 
causality, scientists intervened by reducing salt 
intake in patients with various levels of high blood 
pressure and found in the Dietary Approaches to 
Stop Hypertension (DASH) study that this dietary 
modifi cation caused lowering of blood pressure.5 
It is important to emphasize that the salt reduc-
tion was modest by any standard, a reduction to 
about 100 mmol of salt a day, not enough to raise 
the renin levels to any signifi cant degree.
Th e Salt Institute led the eff ort started by many 
industries to establish a law called the Data Qual-
ity Act (http://www.whitehouse.gov/omb/fedreg/
reproducible.html). Th is is a few-sentence piece 
of legislation stealthily introduced by the lobby as 
an addendum to the budget and rapidly accepted 
without discussion. In this law, Congress directs 
the White House Office of Management and 
Budget to issue guidelines “ensuring and maximiz-
ing the quality, objectivity, utility, and integrity of 
information … disseminated by Federal agencies.” 
Th at is, all data that form the basis of federal regu-
lation should be of the highest quality; who could 
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be against that? Using this law, big business has challenged every 
piece of federal legislation that protects the environment, regulates 
drug makers, or issues dietary recommendations, and even those 
that list certain compounds as carcinogens.6 To reduce criticism, 
the lobbyist who wrote the law (J. Tozzi) has been encouraging 
public-interest groups to use the act for their own purposes, 
including a group that aims to legalize marijuana for health uses. 
A new set of code words has been invented — ‘sound science’ 
versus ‘junk science’ — to overthrow the regulatory rulings. Th eir 
aim is to use this law to make sure that ‘junk science’ (evidence 
for global warming, harmful eff ects of salt in the diet, and so on) 
does not pollute the lives of Americans. In 2003 the Salt Institute 
and the United States Chamber of Commerce used the law to peti-
tion the NIH, challenging the accuracy of the DASH study and its 
applicability to all individuals. Th ey requested the disclosure of 
the raw data on all the patients. Th eir aim is probably to extract 
data on a few patients and show that these few did not respond to 
decreased salt intake with lowering blood pressure. Th ey will then 
publish them and say, See! We told you it is controversial — even 
in the DASH study.
Th e key claim in their petition was that the DASH study does 
not meet the standards of objectivity or its underlying require-
ments of transparency and reproducibility — that without the 
original data the public cannot assess whether there is some 
reason to question the objectivity of the sources. Th e real issue 
seems to be that, according to the Salt Institute, the concept of 
reproducibility is not statistical; rather, any fi nding must apply 
to all of the subgroups. But because the petition was to release 
data rather than to question their accuracy, the NIH construed 
it as falling under the Freedom of Information Act and denied it. 
Th e Salt Institute and the Chamber of Commerce then sued the 
National Heart, Lung, and Blood Institute on the grounds that 
it had violated the Data Quality Act, but the courts dismissed 
the case on the grounds that the plaintiff s did not question the 
correctness of the data and hence had no standing in the case. 
In addition, their suggestion that they had suff ered ‘injury’ by 
the lack of the original raw data apparently did not convince 
the court. Th e NIH also argued that, because these data had 
been subjected to continual peer review at every level of the 
organization, conduct, and publication of the trial, no issue of 
quality was involved. Needless to say, the Salt Institute and the 
Chamber of Commerce appealed the decision, and arguments 
were presented in early February 2006 before the United States 
Court of Appeals (Fourth Circuit) in Virginia. Here they argued 
that they had received “informational injury.” In a lucid opin-
ion, Judge Luttig dismissed the case (http://pacer.ca4.uscourts.
gov/opinion.pdf/051097.P.pdf), concluding that the plaintiff s 
again had no standing. It has been rumored that now the Salt 
Institute will do what it knows best how to do: slip some benign-
sounding legislation into a budget bill that will overturn these 
legal opinions.
Where do we go from here? For one thing, we must continue 
to do research on the subject, but not epidemiological research. 
Th is kind of work simply will not solve any of the problems. It is 
not that I am against epidemiology; how can one be? Th e prob-
lem is that epidemiological studies of issues like diet and blood 
pressure require massive numbers of subjects, which means that 
the information gathered can never be anything but superfi cial 
— with too many centers collecting data; too much variability; 
critical fi ndings such as salt intake that cannot be adequately 
quantifi ed in such a large population; and so on. Th ere has been 
an increase in reports of something called reverse epidemiology; 
that is, results that are counterintuitive. We are told that patients 
are at a higher risk of dying if they have lower cholesterol or 
lower blood pressure when they are on dialysis. I remember a 
study many years ago that showed that people who do not eat 
breakfast have a higher mortality rate. It later turned out that the 
study had included many people with malignancies and, hence, 
anorexia; of course they had had a higher incidence of death. 
Reverse epidemiology probably has the same kind of problem; 
sicker people have lower blood pressure and eat less, so their 
cholesterol is lower. Is this the explanation for the new fi nding by 
Adelman that there is an inverse correlation between salt intake 
and cardiovascular mortality?7 Very likely, I would say: patients 
who went on a low-salt diet probably did so because they had 
seen a doctor and the doctor had prescribed it; those who were 
sicker were probably more likely to stick to the diet, so they were 
likely to have a higher mortality. And at any rate, measurements 
of sodium intake or excretion were not taken here; it was just the 
subjects’ reports of their sodium intake! When are we going to 
start thinking like scientists about this? Let us eject the real junk 
science from this debate.
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